AusBiotech has announced the 2025 appointments to its state committees, which the organisation describes as a key mechanism for hearing from and engaging with the breadth and diversity of its membership nationwide.
The committees provide local insight, strengthen community connections, and ensure AusBiotech’s initiatives remain grounded in the real-world needs of our members.
Comprising leaders from across the life sciences ecosystem, including industry, research, investment, and support services, the committees contribute to shaping AusBiotech’s national agenda through informed engagement and strategic advice.
“Being able to engage our members, hear their collective views, and then appropriately act upon their feedback is a critical part of our ability to deliver on our strategic agenda,” said AusBiotech director of state and committee engagement, Dr Robyn Lindner. “I look forward to working with our state committees to support our membership and the broader life sciences sector.”
More information is available on the committees:
- New South Wales State Committee
- Queensland State Committee
- South Australian State Committee
- Victorian State Committee
- Western Australian State Committee
Outgoing Committee Members
AusBiotech said it also extends its thanks to the outgoing committee members:
Victoria
- Tom Howitt, Interim Chief Executive Officer, Virtura Health;
- Joy Hewitt, Consultant, Research and Industry Engagement, Monash University; and,
- Sam Street, Associate Director, Corporate Advisory, Morgans Financial.
New South Wales
- Peter Brown, Special Counsel, Griffith Hack; and,
- Dr Alison Todd, Chief Scientific Officer and Founder, SpeeDx
Queensland
- Dr Chris Davis (Chair), General Manager, Institute for Glycomics, Griffith University;
- Mark Muller, Finance Director, Cook Australia;
- Scott Power, Director of Research, Morgans Financial; and,
- Professor Bharat Patel, Adjunct Professor, Formerly of Queensland University of Technology - Office of Research.
"These leaders — highly respected and generous with their time — have provided invaluable advice, insight, and stewardship of the life sciences community," said AusBiotech, adding, "AusBiotech looks forward to working closely with our new committee members and chairs to support innovation, collaboration, and commercialisation in every state and territory."